Why the study?
The optimal use of antiplatelet medication during dental procedures remains an open question, highlighted by risks of thrombotic occlusion when antiplatelet therapy is held.
Does holding antiplatelet medication increase the risk of stent thrombosis and acute myocardial infarction in cardiac patients undergoing dental extraction?
Does holding antiplatelet medication increase the risk of stent thrombosis and acute myocardial infarction in cardiac patients undergoing dental extraction?
Holding antiplatelet therapy for dental procedures in patients with prior coronary stents can lead to catastrophic very late stent thrombosis, highlighting the need for multidisciplinary periprocedural management.
Caution advised when interrupting antiplatelet therapy for dental procedures in stented patients; this case leaves open optimal periprocedural strategies.
Multidisciplinary care in healthcare is becoming the preferred approach to optimizing outcome. We present a case in which a patient developed a thrombotic occlusion of the mid left anterior descending coronary artery (very late stent thrombosis) leading to acute myocardial infarction while presenting for a dental extraction. Prior to the dental extraction his antiplatelet medication was held to minimize his risk of bleeding. This raises a question regarding the optimal use of antiplatelet medication during dental procedures. In complex cardiac patients we propose a multidisciplinary approach to antiplatelet management during the periprocedural period.
No takes yet. Share an insight, caveat, or question.
Agarwal et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: